Postchemotherapy tumor volume as a prognostic indicator in Wilms tumor: A single-center experience from South India.

Abstract

Optimal risk stratification is the key to minimizing relapse and toxicity in children with Wilms tumor (WT). The study evaluated poor tumor volume response to chemotherapy as a risk factor that predicts relapse. Children with WT who were treated between 2005 and 2020 at the center were analyzed. Tumor volumes at the time of diagnosis and after preoperative chemotherapy were calculated from cross-sectional imaging. The International Society of Paediatric Oncology (SIOP)-WT-2001 protocol was used for treatment. The area under a receiver operating characteristic curve was estimated to ascertain the ability of tumor volume to predict relapse. Ninety-five patients with a median age of 40months were included. A postchemotherapy tumor volume cutoff of 270ml was ascertained to have the best predictive value for relapse. Patients with a tumor volume of <270ml following preoperative chemotherapy had a better 3-year event-free survival (EFS) than those with a tumor volume of ≥270ml (89.8% ± 4.0% vs. 57.4% ± 12.5%, p=.001). The data demonstrated that a tumor volume of ≥270ml after chemotherapy was associated with an increased risk of relapse (hazard ratio [HR]: 5.3, p=.006). The EFS in patients with an epithelial or stromal type of histopathology was not affected by the tumor volume response (p=.437). Conversely, patients with other types of intermediate-risk histopathology who had a poor tumor volume response had an inferior survival (3-year EFS 51.4% ± 18.7%, p=.001). A postchemotherapy tumor volume cutoff of ≥270ml emerged as a strong predictor of relapse in a low- and middle-income country (LMIC) center study of WT treated with the SIOP protocol.